PIK3CA mutation detection by circulating tumor cell sequencing guides the effective PI3K inhibitor treatment of a patient with hormone receptor-positive breast cancer transformed into triple-negative breast cancer: A case report.
Saved in:
| Title: | PIK3CA mutation detection by circulating tumor cell sequencing guides the effective PI3K inhibitor treatment of a patient with hormone receptor-positive breast cancer transformed into triple-negative breast cancer: A case report. |
|---|---|
| Authors: | Zhang J; Department of Breast Surgery, Xuzhou Hospital Affiliated to Jiangsu University (Xuzhou Cancer Hospital), Xuzhou, Jiangsu, People's Republic of China., Pei J; Department of Breast Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China., Hao G; Department of Breast Surgery, Xuzhou Hospital Affiliated to Jiangsu University (Xuzhou Cancer Hospital), Xuzhou, Jiangsu, People's Republic of China., Meng Y; Department of Breast Surgery, Xuzhou Hospital Affiliated to Jiangsu University (Xuzhou Cancer Hospital), Xuzhou, Jiangsu, People's Republic of China., Li F; Department of Breast Surgery, Xuzhou Hospital Affiliated to Jiangsu University (Xuzhou Cancer Hospital), Xuzhou, Jiangsu, People's Republic of China., Xu H; Nanjing RontiMed Laboratory Co., Ltd, Nanjing, Jiangsu, People's Republic of China., Liu H; The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. |
| Source: | Medicine [Medicine (Baltimore)] 2026 May 15; Vol. 105 (20), pp. e48622. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42152370 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PIK3CA mutation detection by circulating tumor cell sequencing guides the effective PI3K inhibitor treatment of a patient with hormone receptor-positive breast cancer transformed into triple-negative breast cancer: A case report. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Breast Surgery, Xuzhou Hospital Affiliated to Jiangsu University (Xuzhou Cancer Hospital), Xuzhou, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Pei+J%22">Pei J</searchLink>; Department of Breast Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Hao+G%22">Hao G</searchLink>; Department of Breast Surgery, Xuzhou Hospital Affiliated to Jiangsu University (Xuzhou Cancer Hospital), Xuzhou, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Meng+Y%22">Meng Y</searchLink>; Department of Breast Surgery, Xuzhou Hospital Affiliated to Jiangsu University (Xuzhou Cancer Hospital), Xuzhou, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Li+F%22">Li F</searchLink>; Department of Breast Surgery, Xuzhou Hospital Affiliated to Jiangsu University (Xuzhou Cancer Hospital), Xuzhou, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Xu+H%22">Xu H</searchLink>; Nanjing RontiMed Laboratory Co., Ltd, Nanjing, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Liu+H%22">Liu H</searchLink>; The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985248R%22">Medicine</searchLink> [Medicine (Baltimore)] 2026 May 15; Vol. 105 (20), pp. e48622. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Case Reports – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2985248R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1536-5964 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200257974%22">00257974 </searchLink><i>NLM ISO Abbreviation: </i>Medicine (Baltimore) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42152370 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/MD.0000000000048622 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e48622 Titles: – TitleFull: PIK3CA mutation detection by circulating tumor cell sequencing guides the effective PI3K inhibitor treatment of a patient with hormone receptor-positive breast cancer transformed into triple-negative breast cancer: A case report. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Pei J – PersonEntity: Name: NameFull: Hao G – PersonEntity: Name: NameFull: Meng Y – PersonEntity: Name: NameFull: Li F – PersonEntity: Name: NameFull: Xu H – PersonEntity: Name: NameFull: Liu H IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 05 Text: 2026 May 15 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1536-5964 Numbering: – Type: volume Value: 105 – Type: issue Value: 20 Titles: – TitleFull: Medicine Type: main |
| ResultId | 1 |
